Trial Profile
Phase II Study of Carboplatin + Pemetrexed in chemotherapy-naive patients with advanced non-squamous non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 May 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 12 May 2011 New trial record